Effect of the profile of antigen delivery on antibody responses in mice

Journal of Controlled Release

Volumn 43, Issue 1, 1997, Pages 75-80

  Walduck, A K ^a   Opdebeeck, J P ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Antigen delivery; Bovine serum albumin; Mini osmotic pump; Vaccination; Vaccine implant

Indexed keywords

BOVINE SERUM ALBUMIN;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; IMMUNE RESPONSE; INJECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PUMP; SUBCUTANEOUS DRUG ADMINISTRATION; VACCINATION;

EID: 0031060395     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(96)01472-1     Document Type: Article

References (16)

1. R. Langer and J. Folkman, Polymers for the sustained release of proteins and other macromolecules. Nature 263 (1976) 797-799.
2. R. Langer, Polymers for the sustained release of macromolecules: their use in a single-step method of immunization. Methods Enzymol. 73 (1981) 57-75.
3. I. Preis and R.S. Langer, A single-step immunisation by sustained antigen release. J. Immunol. Methods 28 (1979) 193-197.
4. J.P. Opdebeeck and I.G. Tucker, A cholesterol implant used as a delivery system to immunise mice with bovine serum albumin. J. Control. Release 23 (1993) 271-279.
5. M.Z. Khan, I.G. Tucker and J.P. Opdebeeck, Cholesterol and lecithin implants for sustained release of antigen: release and erosion in vitro, and antibody response in mice. Int. J. Pharm. 76 (1991) 161-170.
6. M.Z. Khan, I.G. Tucker and J.P. Opdebeeck, Evaluation of cholesterol-lecithin implants for sustained delivery of antigen: release in vivo and single-step immunisation of mice. Int. J. Pharm. 90 (1993) 255-262.
7. S.Z. Kerenyi and S.L. Hartgraves, Premature excess release from the Alzet osmotic pump. Pharm. Biochem. Behav. 27 (1987) 199-201.
8. D.J. Marciani, C.R. Kensil, G.A. Beltz, C. Hung, J. Cronier and A. Aubert, Genetically-engineered subunit vaccine against feline leukaemia virus: protective response in cats. Vaccine 9 (1991) 89-96.
9. D.W. Dresser, Specific inhibition of antibody production. II. Paralysis induced in adult mice by small quantities of protein antigen. Immunology 5 (1962) 378-388.
10. A.A. Amkraut, S.I. Yum and M.B. Rittenberg, Specific suppression of IgG plaque forming cells (PFC) by continuous administration of antigen from an implantable delivery system. Fed. Proc. 35 (1976) 675.
11. C. Ehrenhofer and J.P. Opdebeeck, The effects of continuous and intermittent delivery of antigens of Boophilus microplus on the development of murine antibodies. Vet. Parasitol. (1995) (in press).
12. J.G. Hu, T. Yokoyama and T. Kitagawa, Studies on the optimal immunization schedule of experimental animals. V. The effects of the route of injection, the content of Mycobacteria in Freund's adjuvant and the emulsifying antigen. Chem. Pharm. Bull. 38 (1990) 1961-1965.
13. C.L. Schwartzkoff, P.R. Lehbrach, M.L. Ng and A. Poi, The effect of time between doses on serological response to a recombinant multivalent pilus vaccine against footrot in sheep. Aust. Vet. J. 70 (1993) 127-129.
14. D.W. Talmage and F.J. Dixon, The influence of adjuvants on the elimination of soluble protein antigens and the associated antibody responses. J. Infect. Dis. 93 (1969) 176-180.
15. D.L. Wise, D.J. Trantalo, R.T. Marino and J.R Kitchell, Opportunities and challenges in the design of implantable biodegradable polymeric systems for the delivery of antimicrobial agents and vaccines. Adv. Drug Deliv. Rev. 1 (1987) 19-30.
16. L.A. Chedid, Adjuvants of immunity. Ann. Inst. Pasteur/ Immunol. 136D (1985) 283-291.